Show simple item record

dc.contributor.authorKenny, Rose
dc.contributor.authorFeeney, Joanne
dc.date.accessioned2025-02-13T08:45:58Z
dc.date.available2025-02-13T08:45:58Z
dc.date.issued2022
dc.date.submitted2022en
dc.identifier.citationFeeney J, Kenny R.A, Hair cortisol as a risk marker for increased depressive symptoms among older adults during the COVID-19 pandemic, Psychoneuroendocrinology, 143, 2022, 105847-en
dc.identifier.otherY
dc.descriptionPUBLISHEDen
dc.description.abstractDetermining pre-existing biological risk markers of incident depression and other mental health sequelae after exposure to a new stressor would help identify vulnerable individuals and mechanistic pathways. This study investigated primarily whether hair cortisol predicted elevated depressive symptoms in middle-aged and older adults during the COVID-19 pandemic, 6 years later. A secondary aim was to deduce whether any association differed by sex. Methods: We studied 1025 adults aged 50 and older (75% female) as part of The Irish Longitudinal Study on Ageing. Hair cortisol samples were collected at 2014 (Wave 3) and depressive symptoms were assessed using the 8-item Center for Epidemiological Studies Depression Scale in 2014 (Wave 3), 2016 (Wave 4), 2018 (Wave 5) and again in 2020 as part of TILDA’s COVID-19 Study. Hierarchical mixed effects logistic regression models were applied to investigate the association between cortisol levels and clinically significant depressive symptoms before and during the COVID-19 pandemic. Results: In a full covariate adjusted model there was a significant interaction between cortisol and wave on depressive symptoms (χ2 = 8.5, p = .03). Cortisol was positively and significantly associated with elevated depressive symptoms during the COVID-19 Study (OR =1.3, 95% CI 1.11, 1.56, p = .003), and was associated with an increased likelihood of reporting clinically significant depressive symptoms during first year of the COVID-19 pandemic, when compared with before, OR = 1.4, 95% CI 1.05, 1.9, p = .015. There was no evidence of effect modification by sex. Conclusions: Higher hair cortisol, assessed 6 years previously, predicted clinically significant depressive symp- toms among middle-aged and older adults during (but not before) the pandemic. Findings suggest a biological phenotype which denotes increased susceptibility to the negative impact of environmental stress on psycho- logical health.en
dc.format.extent105847en
dc.language.isoenen
dc.relation.ispartofseriesPsychoneuroendocrinology;
dc.relation.ispartofseries143;
dc.rightsYen
dc.subjectCortisolen
dc.subjectStressen
dc.subjectDepressionen
dc.subjectCOVID-19en
dc.titleHair cortisol as a risk marker for increased depressive symptoms among older adults during the COVID-19 pandemicen
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/feeneyjo
dc.identifier.peoplefinderurlhttp://people.tcd.ie/rkenny
dc.identifier.rssinternalid254825
dc.identifier.doihttp://dx.doi.org/10.1016/j.psyneuen.2022.105847
dc.rights.ecaccessrightsopenAccess
dc.identifier.rssurihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85133473514&doi=10.1016%2fj.psyneuen.2022.105847&partnerID=40&md5=714057341703db4acecc544fa8e68ded
dc.identifier.orcid_id0000-0001-9872-2025
dc.status.accessibleNen
dc.identifier.urihttps://hdl.handle.net/2262/110857


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record